Goldenhar Sendromu Goldenhar Sendromu Astım - Kardiyolojik Hastalık Profillendirmesi Ve Hava Kalitesi Değerlendirmesi
Fırsatçı bir patojen olan Acinetobacter baumannii önemli bir nozokomiyal infeksiyon etkenidir. Antibiyotiklere çoklu direnç geliştirdiği için direnç oranları yüksektir ve infeksiyonlarının tedavisi zordur. Çalışmamızda hastanemizdeki A.baumanniisuşlarının antibiyotik direnç oranlarının belirlenmesi amaçlanmıştır. Ocak 2014 ve Mayıs 2016 tarihleri arasında Erzurum Bölge Eğitim ve Araştırma Hastanesi'nde çeşitli servislerde takip edilen 236 hastadan izole edilen, A.baumanniisuşunun antibiyotik duyarlılık test sonuçları değerlendirilmiştir. A.baumanniisuşlarının antibiyotik direnç oranları BD Phoenix (BD Diagnostic Systems, Sparks, MD) otomatize sistemi kullanılarak belirlenmiştir. Bu kültür sonuçları Enfeksiyon Kontrol Komitesi tarafından kaydedilen Ulusal Hastane Enfeksiyonları programından (www.infline.saglik.gov.tr) retrospektif olarak incelenmiştir.A.baumanniisuşlarında amikasine %77.4, ampisilin/sulbaktama %96.7, aztreonama %100, sefepime %97.9, seftriaksona %100, seftazidime %97.9, siprofloksasine %97.4, kolistine %1.4, genta- misine %74.4, imipeneme %96.7, levofloksasine %96.1,meropeneme %98.6, piperasilin/ tazobaktama % 98.1, trimetoprim/sülfametoksazole %66.5, sefoperazon/sulbaktama %98.8, tigesikline %100 direnç saptanmıştır. Antibiyotiklere direnç oranlarının çok yüksek olduğu, en etkili antibiyotiğin kolistin,ikinci en etkili antibiyotiğin trimetoprim/sülfametoksazol olduğu görülmüştür. A.baumanniisuşlarının etken olabileceği düşünülen enfeksiyonlarda kültür sonucu çıkıncaya kadar ampirik tedavi düzenlenirken kolistin ve trimetoprim/sülfametoksazol kombinasyonunun iyi bir seçenek olduğu tespit edilmiştir.
Erzurum Bölge Eğitim ve Araştırma Hastanesi'nde Tespit Edilen Acinetobacter Baumannii Suşlarının Antibiyotik Direnç Oranları
Acinetobacter baumannii is an opportunistic pathogen and an important nosocomial infection patogen. As it might develop multi resistance to antibiotics ,Acinetobacter baumannii resistance ratios are high and treatment of their infections are difficult. Our study aims to determine resistance ratios of A.baumannii in ourhospital.This study included antibiotic sensitivity test results of A.baumanniistrains isolated from cultures of 236 patients followed in different clinics of Erzurum Regional Training and Research Hospital between January 2014 and May 2016 A.baumannii antibiotic sensitivity testing was determined by BD Phoenix (BD Diagnostic Systems, Sparks, MD) automatic system. The culture results were obtained retrospectively from national hospital infection programme (www. infline.saglik.gov.tr), that have been recorded by infection control comittee.Resistanceratios of A.baumanniistrains were as follows: amikacin 77.4%, ampicillin/ sulbactam96.7%, aztreonam 100%, cefepime 97.9%, ceftriaxone 100%, ceftazidime 97.9%, ciprofloxacin 97.4%, colistin 1.4%, gentamycin 74.4%, imipenem 96.7%, levofloxacin 96.1%, meropenem 98.6%, piperacillin/ tazobactam 98.1%, trimetoprim/sulfamethoxazole 66.5%, tigecyline 100%.It is found that antibiotic resistance ratios of A.baumanniiisolated in our hospital were very high and the most effective antibiotic was colistin followed by trimetoprim/sulfamethoxazole. It was determined that colistine and trimethoprime/sulphemetaxazole combination was a good choice in deciding ampiric treatment of possible A Baumonnii infections before culture results were obtained.
___
- 1. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn CW. The nonfermentative Gram-negativebacilli, "Color Atlas and Textbook of Diagnostic Microbiology, 4.baskı" kitabında s.185-242, J.B. LippincottCo., Philadelphia (1992).
- 2. Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter baumannii: a universal threatto publichealth? Int J Antimicrob Agents 2008;32(2):106-19.
- 3. Struelens MJ, Carlier E, Maes N, Serruys E, Quint WG, van Belkum A. Nosocomial colonization and infection withmultiresistant Acinetobacter baumannii: outbreak delineation using DNA macro restriction analysis and PCR-finger-printing, J Hosp Infect 1993;25(1):15-32.
- 4. Towner KJ. Acinetobacter: an oldfriend, but a newenemy, Rev J Hosp Infect 2009;73(4):355-63.
- 5. Karabay O, Yahyaoğlu M, Öğütlü A, Sandikçi Ö, Tuna N, Ceylan S. Factors associated with mortality in Acinetobacter baumannii infected intensive care unit patients, Mikrobiyol Bul 2012;46(2):335-7.
- 6. Zer Y, Akın FEÖ, Namıduru M. Evalution of Resistance to various antibiotics in Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from blood cultures of intensive care patients, İnfeksiyon Derg 2007;21(4):193-6.
- 7. Balcı M, Bitirgen M, Kandemir B, Türk Arıbaş E, Eraymen İ. Antibiotic susceptibility of nosocomial Acinetobacter baumannii strains, ANKEM Derg 2010;24:28-33
- 8. Şahin Ü, Adiloğlu AK , Karakoç AE , Önde U , Altun HU, Öztürk A. Antıbıotıc resıstance profıle of Acınetobacter baumannıı straıns ısolated from our hospıtal,. S.B Ankara Eğitim ve Araştırma Hastanesi Tıp Derg 2013;46(3):124-8.
- 9. Direkel Ş, Uzunoğlu E, Keleş S, Yapar K. Antibiotic resistance rates of Acinetobacter Baumannii strains isolated from various clinical samples in Giresun Prof. Dr. Atilla İlhan Ozdemir State Hospital, GMJ 2015;26(3):92-6.
- 10. Batirel A, Balkan II, Karabay O, Agalar C, Akalin S, Alici O, Alp E, Altay FA, Altin N, Arslan F, Aslan T, Bekiroglu N, Cesur S, Celik AD, Dogan M, Durdu B, Duygu F, Engin A, Engin DO, Gonen I, Guclu E, Guven T, Hatipoglu CA, Hosoglu S, Karahocagil MK, Kilic AU, Ormen B, Ozdemir D, Ozer S, Oztoprak N, Sezak N, Turhan V, Turker N, Yilmaz H.Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infectionsEur J Clin Microbiol Infect Dis. 2014 Aug;33(8):1311-22
- 11. Balkan II, Batirel A, Karabay O, Agalar C, Akalin S, Alici O, Alp E, Altay FA, Altin N, Arslan F, Aslan T, Bekiroglu N, Cesur S8, Celik AD, Dogan M, Durdu B, Duygu F, Engin A, Engin DO, Gonen I, Guclu E, Guven T, Hatipoglu CA, Hosoglu S, Karahocagil MK, Kilic AU, Ormen B, Ozdemir D, Ozer S, Oztoprak N, Sezak N, Turhan V, Turker N, Yilmaz H.Comparison of colistin monotherapy and non-colistin combinations in the treatment of multidrug resistant Acinetobacter spp. bloodstream infections: a multicenter retrospective analysis.Indian J Pharmacol. 2015 Jan-Feb;47(1):95-100.
- 12. Altın N, Cesur S, Toros GY, Koldaş K, Solgun G, Altıntop A, Tekin A, Şencan İ. Antibiotic susceptibilities of Acinetobacter baumannii strains isolated from several clinical samples of hospitalized patients at Etlik Training and Research Hospital, Ortadogu Medıcal Journal 2013;5(3):143-7.
- 13. Maragakis LL, Perl TM. Acinetobacter baumannii: Epidemiology, antimicrobial resistance and treatment options, Clin Infect Dis 2008;46(8):1254- 63.
- 14. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology, Clin Microbiol Infect 2006;12(9):826-36.
- 15. Özdem B, Gürçelik FÇ, Çelikbilek N, Balıkçı H. Açıkgöz ZC. Çeşitli Klinik Örneklerden 2007-2010 Yıllarında İzole Edilen Acinetobacter Türlerinin Antibiyotik Direnç Profilleri. Antibiotic Resistance Profiles of Acinetobacter Species Isolated from Several Clinical Samples Between 2007-2010, Mikrobiyol Bul 2011;45(3):526-34.
- 16. Evren E ,Göçmen JS , Demirbilek M, Alışkan HE. Imipenem, Meropenem, Colistin, Amikacin and Fosfomycin Susceptibilities of Multidrug Resistant Acinetobacter baumannii Strains Isolated from Various Clinical Specimens, GMJ 2013;24(1):1-4.
- 17. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8(12):751-62.
- 18. Fishbain J, Peleg AY. Treatment of Acinetobacter infections, Clin Infect Dis 2010;51(1):79-84.
- 19. Jaggi N, Sissodia P, Sharma L. Acinetobacter baumannii isolates in a tertiary care hospital: Antimicrobia lresistance and clinical signifcance, J Microbiol Infect Dis. 2012:2(2): 57-63.
- 20. Liang W, Liu X, Huang J, Zhu DM, Li J, Zhang J. Activities of colistin and minocycline-based combinations agains textensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients, BMC Infect Dis 2011; 11:109 PMid:21521536 PMCid:PMC3098177
- 21. Doğan M, Taşbent FE , Feyzioğlu B, Baykan M. Investigation of Colistin, Tigecycline and Other Antibiotic Resistance Profiles of Acinetobacter Species Isolated from Several Clinical Specimens, ANKEM Derg 2014;28(4):138-43.
- 22. Altunok ES, Koç MM. Comparison of Antibiotic Resistance Rates in Acinetobacter Strains Isolated from Intensive Care , ANKEM Derg 2014;28(1):1-7.
- 23. Özdemir M, Erayman İ, Gündem NS, Baykan M,Baysal B. Investigation of Colistin, Tigecycline and Other Antibiotic Resistance Profiles of Acinetobacter Species Isolated from Several Clinical Specimens, ANKEM Derg 2009;23(3):127-3.
- 24. Kurtoğlu MG, Opuş A, Kaya M, Keşli R, Güzelant A, Yüksekkaya Ş. Antimicrobial Resistance of Acinetobacter baumannii Strains Isolated from Clinical Samples in an Education and Research Hospital (2008-2010), ANKEM Derg 2011;25(1):35-41.
- 25. Savcı Ü, Özveren G, Yenişehirli G, Bulut Y, Özdaş S. Klinik örneklerden izole edilen Acinetobacter baumannii suşlarının in-vitro duyarlılık durumları. In-vitro susceptibility of Acinetobacter baumannii strains isolated from clinical specimens, Turkısh Journal of Clinics and Laboratory 2015;6(1):24- 9.